GENO — Genovis AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	60.5	61	93	102	158
Cost of Revenue
Gross Profit	39.1	38.9	59.3	59.7	114
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	50.5	57.9	68.5	94.1	104
Operating Profit	10.1	3.14	24.5	8.28	54.2
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	9.67	2.15	24.6	8	54.9
Provision for Income Taxes
Net Income After Taxes	9.55	6.45	24.8	11.2	61.5
Net Income Before Extraordinary Items
Net Income	9.55	6.45	24.8	11.2	61.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9.55	6.45	24.8	11.2	61.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.151	0.126	0.381	0.259	0.955
Dividends per Share